. 2020 Nov 27;2(1):vdaa163. doi: 10.1093/noajnl/vdaa163

Table 1.

Demographics and Clinical Characteristics of the Patients in This Study

	CD133^low/CD109^high	Others	P-value
No. of patients	15	22
Age	54.0 ± 10.2	48.2 ± 9.3	NS
Sex (M/F)	8/7	13/9	NS
% of distant recurrence	33.3% (5/15)	27.3% (6/22)	NS
Radiotherapy between first and second surgery (%)	100% (15/15)	95.5% (21/22）	NS
Chemotherapy between first and second surgery (%)	80% (12/15)	95.5% (21/22)	NS
Delta-CD133	−1.19 ± 0.98	0.21 ± 0.85	5.02E−5
Delta-CD109	0.93 ± 0.76	−0.20 ± 0.77	9.58E−5

NS, not significant.